يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"Michael J Chisamore"', وقت الاستعلام: 1.18s تنقيح النتائج
  1. 1
    دورية أكاديمية
    First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

    المؤلفون: Stephane Champiat, Aurélien Marabelle, Anna Spreafico, Mehmet Altan, Todd M Bauer, Osama Rahma, Karen A Autio, Neeta Somaiah, Meredith McKean, Aaron R Hansen, Jan H M Schellens, Willeke Ros, F Stephen Hodi, Jeffrey S Weber, John V Heymach, Herbert Struemper, Sandrine Aspeslagh, Daniel C Cho, Jennifer K Litton, Axel Hoos, Vincent K Lam, Emmett V Schmidt, Sophie Postel-Vinay, Frans L Opdam, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore

    المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://jitc.bmj.com/content/11/3/e005301.fullTest; https://doaj.org/toc/2051-1426Test

    الوصول الحر: https://doaj.org/article/cede222f65c649b89ade485245fc9ae7Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.

    المؤلفون: Michael J Chisamore, Michael E Cunningham, Osvaldo Flores, Hilary A Wilkinson, J Don Chen

    المصدر: PLoS ONE, Vol 4, Iss 5, p e5624 (2009)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    العلاقة: http://europepmc.org/articles/PMC2680043?pdf=renderTest; https://doaj.org/toc/1932-6203Test

    الوصول الحر: https://doaj.org/article/ed8a3f51a2924496a2d2725845007feeTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

    المؤلفون: Hope S. Rugo, Peter Kabos, J. Thad Beck, Guy Jerusalem, Hans Wildiers, Elena Sevillano, Luis Paz-Ares, Michael J. Chisamore, Sonya C. Chapman, Anwar M. Hossain, Yanyun Chen, Sara M. Tolaney

    المصدر: npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2374-4677Test

    الوصول الحر: https://doaj.org/article/273e69685df94ce99e4481cd2a74cdd4Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    PD13-08 CORE1: PHASE 2 SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)

    المؤلفون: Roger Li, Gary Steinberg, Edward M. Uchio, Donald Lamm, Paras Shah, Ashish M. Kamat, Trinity J Bivalacqua, Vignesh Packiam, Michael J. Chisamore, John Mcadory, Paola Grandi, Nataliya Hnat, James Burke

    المصدر: Journal of Urology. 209

    مصطلحات موضوعية: Urology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::96f1008735518b30ce5004112e9b7856Test
    https://doi.org/10.1097/ju.0000000000003260.08Test


    أضف إلى المفضلة
  5. 5
    Supplementary Data from Estrogen-related receptor-α antagonist inhibits both estrogen receptor–positive and estrogen receptor–negative breast tumor growth in mouse xenografts

    المؤلفون: J. Don Chen, Osvaldo Flores, Hilary A. Wilkinson, Michael J. Chisamore

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23713c69bb8f6ce03db111a76be2e540Test
    https://doi.org/10.1158/1535-7163.22484927Test


    أضف إلى المفضلة
  6. 6
    Data from Estrogen-related receptor-α antagonist inhibits both estrogen receptor–positive and estrogen receptor–negative breast tumor growth in mouse xenografts

    المؤلفون: J. Don Chen, Osvaldo Flores, Hilary A. Wilkinson, Michael J. Chisamore

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00153ec0baacb68c1003cc7d76f61ebTest
    https://doi.org/10.1158/1535-7163.c.6531659Test


    أضف إلى المفضلة
  7. 7
    Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)

    المؤلفون: Benjamin Levy, Fabrice Barlesi, Luis Paz-Ares, Jaafar Bennouna, Mustafa Erman, Enriqueta Felip, Dolores Isla, Hye Ryun Kim, Sang-We Kim, Jeannick Madelaine, Olivier Molinier, Mustafa Özgüroğlu, Delvys Rodríguez Abreu, Abidemi Adeniji, Robert M. Lorence, Isabelle Voccia, Michael J. Chisamore, Jonathan W. Riess

    المساهمون: Institut Català de la Salut, [Levy B] Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Washington, DC, USA. [Barlesi F] Aix Marseille University, CNRS, INSERM, CRCM, Assistance Publique Hôpitaux de Marseille, Marseille, France. Gustave Roussy Cancer Campus, Villejuif, France. [Paz-Ares L] Department of Medical Oncology, University Hospital 12 De Octubre, Madrid, Spain. [Bennouna J] Department of Pneumology, Thoracic Oncology, University Hospital - Nantes, Nantes, France. [Erman M] Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. [Felip E] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Isla D] Department of Medical Oncology, University Hospital Lozano Blesa, Zaragoza, Spain, Vall d'Hebron Barcelona Hospital Campus, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Hôpital Foch [Suresnes], Hacettepe University = Hacettepe Üniversitesi, Vall d'Hebron University Hospital [Barcelona], Yonsei University College of Medicine [Séoul, Corée du Sud], Service de pneumologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Le Mans (CH Le Mans)

    المصدر: Scientia
    LUNG CANCER
    LUNG CANCER, 2022, 166, pp.107-113. ⟨10.1016/j.lungcan.2022.01.023⟩

    مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms [DISEASES], Cancer Research, Lung Neoplasms, [SDV]Life Sciences [q-bio], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Middle Aged, Afatinib, Antibodies, Monoclonal, Humanized, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Quimioteràpia combinada, ErbB Receptors, neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares [ENFERMEDADES], Oncology, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Avaluació de resultats (Assistència sanitària), Humans, Female, Pulmons - Càncer - Tractament

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6154ee0d6f5200eddf5a3d35311b7fTest
    https://doi.org/10.1016Test/j.lungcan.2022.01.023


    أضف إلى المفضلة
  8. 8
    MP54-03 CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)

    المؤلفون: Roger Li, Gary Steinberg, Donald Lamm, Ed M. Uchio, Paras Shah, Ashish M. Kamat, Nataliya Hnat, Michael J. Chisamore, Paola Grandi, James Burke

    المصدر: Journal of Urology. 207

    مصطلحات موضوعية: Urology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0b0ef6c736c35d4eb649ec80b9ac742eTest
    https://doi.org/10.1097/ju.0000000000002633.03Test


    أضف إلى المفضلة
  9. 9
    First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

    المؤلفون: Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H M Schellens, Jennifer K Litton, Sandrine Aspeslagh, Karen A Autio, Frans L Opdam, Meredith McKean, Neeta Somaiah, Stephane Champiat, Mehmet Altan, Anna Spreafico, Osama Rahma, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Herbert Struemper, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore, Emmett V Schmidt, Axel Hoos, Aurelien Marabelle, Jeffrey S Weber, John V Heymach

    المصدر: Journal for ImmunoTherapy of Cancer. 11:e005301

    مصطلحات موضوعية: Pharmacology, Cancer Research, Oncology, Immunology, Molecular Medicine, Immunology and Allergy

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0dbbca2e6c06fe0b93fd49e0465c00d1Test
    https://doi.org/10.1136/jitc-2022-005301Test


    أضف إلى المفضلة
  10. 10
    Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells

    المؤلفون: William J. Ray, Chang Bai, Stephen E. Alves, Tara E. Cusick, Brenda L Pennypacker, Evan E. Opas, Michael J. Chisamore, Carlo J. Gambone, Damien Ferraro, David J. Bettoun, Azriel Schmidt, Hilary A. Wilkinson, Angela Scafonas, Michael A. Gentile, Osvaldo A. Flores, Paul Hodor, Meissner Robert S, James J. Perkins

    المصدر: The Journal of Steroid Biochemistry and Molecular Biology. 143:29-39

    مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Apoptosis, urologic and male genital diseases, Antiandrogen, Biochemistry, Rats, Sprague-Dawley, Mice, Prostate cancer, Anabolic Agents, Endocrinology, Tumor Cells, Cultured, Combinatorial Chemistry Techniques, Reverse Transcriptase Polymerase Chain Reaction, Chemistry, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Androgens, Molecular Medicine, Female, medicine.drug, medicine.medical_specialty, Bicalutamide, medicine.drug_class, Blotting, Western, Breast Neoplasms, Real-Time Polymerase Chain Reaction, DU145, Internal medicine, LNCaP, Androgen Receptor Antagonists, medicine, Animals, Humans, RNA, Messenger, Molecular Biology, Cell Proliferation, Prostatic Neoplasms, Cell Biology, medicine.disease, Androgen, Rats, Mice, Inbred C57BL, Androgen receptor, Selective androgen receptor modulator, Azasteroids, Cancer research, Carbamates

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05fa5f1d9ca8a07a5b1af5c4fa5cd5bTest
    https://doi.org/10.1016Test/j.jsbmb.2014.02.005


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث